Gilead Sciences
GILD
1,189 hedge funds and large institutions have $116B invested in Gilead Sciences in 2014 Q1 according to their latest regulatory filings, with 162 funds opening new positions, 512 increasing their positions, 412 reducing their positions, and 58 closing their positions.
179% more first-time investments, than exits
New positions opened: 162 | Existing positions closed: 58
24% more repeat investments, than reductions
Existing positions increased: 512 | Existing positions reduced: 412
8% more funds holding
Funds holding: 1,100 → 1,189 (+89)
6% less capital invested
Capital invested by funds: $124B → $116B (-$7.41B)
26% less funds holding in top 10
Funds holding in top 10: 151 → 112 (-39)
48% less call options, than puts
Call options by funds: $1.3B | Put options by funds: $2.47B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.64B |
| 2 |
Goldman Sachs
New York
|
+$571M |
| 3 |
Temasek Holdings
Singapore
|
+$543M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$266M |
| 5 |
Barclays
London,
United Kingdom
|
+$242M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.21B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.03B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$470M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$375M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$311M |
GILD Hedge Fund Activity: Q1 2014 in Review
1,189 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2014, worth a combined $116B — down 6% from $124B a quarter earlier.
Buyers outnumbered sellers: 162 funds opened new GILD positions and 58 closed out — a net gain of 104 holders — while 512 added to existing stakes and 412 trimmed.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $3.64B. The largest seller was Capital World Investors, cutting an estimated $1.21B.
- 1,189 institutional investors held Gilead Sciences (GILD) as of Q1 2014, up from 1,100 in Q4 2013.
- Funds reported $116B of Gilead Sciences stock for Q1 2014, down 6% quarter-over-quarter.
- 162 funds opened new Gilead Sciences positions in Q1 2014 and 58 closed out, a net change of +104 holders.
- The largest Gilead Sciences buyer in Q1 2014 was BNP Paribas Financial Markets, an estimated $3.64B added.
- The largest Gilead Sciences seller in Q1 2014 was Capital World Investors, an estimated $1.21B sold.
Based on aggregated 13F filings for Q1 2014.